Conclusions: In participants with overweight or obesity, 2.4 mg of semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body weight
Huang X, Huang L, Lu J, Cheng L, Wu D, Li L, et al
BLUEPRINT NEWSLETTER Health protocols that actually work We will teach you how to be healthy, for free
valve disorders or defects
Since we are not able to exploit the full benefit of GLP-1 and its analogs with current drug delivery systems [79], further research will be essential to fully elucidate the mechanism and/or site(s) of action of GLP-1 and its analogs, enabling next-generation therapeutics for type 2 diabetes